BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
525 results:

  • 1. Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score-matched cohort study.
    Grönroos-Korhonen MT; Koskenvuo LE; Mentula PJ; Nykänen TP; Koskensalo SK; Leppäniemi AK; Sallinen VJ
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38597158
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment.
    Elmetwalli A; Abdel-Monem MO; El-Far AH; Ghaith GS; Albalawi NAN; Hassan J; Ismail NF; El-Sewedy T; Alnamshan MM; ALaqeel NK; Al-Dhuayan IS; Hassan MG
    Med Oncol; 2024 Apr; 41(5):106. PubMed ID: 38575697
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survey of lived experiences and challenges in hepatitis B management and treatment.
    Freeland C; Adjei C; Wallace J; Wang S; Hicks J; Adda D; James C; Cohen C
    BMC Public Health; 2024 Apr; 24(1):944. PubMed ID: 38566070
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Aldehyde Dehydrogenase 2 (aldh2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay.
    Ferreira IC; Torrejón E; Abecasis B; Alexandre BM; Gomes RA; Verslype C; van Pelt J; Barbas A; Simão D; Bandeiras TM; Bortoluzzi A; Rebelo SP
    SLAS Discov; 2024 Apr; 29(3):100154. PubMed ID: 38521503
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development.
    Yang D; Hu Y; Yang J; Tao L; Su Y; Wu Y; Yao Y; Wang S; Ye S; Xu T
    J Pharmacol Exp Ther; 2024 Apr; 389(2):163-173. PubMed ID: 38453527
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Simmons DJ; Valerio SJ; Thomas DS; Healey MJ; Jiang Z; Levingston Mac Leod JM; Lin Y; Sah J
    Adv Ther; 2024 Apr; 41(4):1711-1727. PubMed ID: 38443649
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma.
    Liu H; Gan XM; Sun JM; Yang Q; Zhang DZ; Zuo YQ; Liu FL; Li B; Tan QL; Zhang J
    Int Immunopharmacol; 2024 Mar; 130():111510. PubMed ID: 38422766
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
    Pan L; Zhang Y; Gao Y; Qiu J
    Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
    Yau T; Kaseb A; Cheng AL; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Milwee S; Wang Z; Curran D; Kelley RK; Rimassa L
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):310-322. PubMed ID: 38364832
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic CT of colorectal cancer with artificial intelligence iterative reconstruction: A clinical evaluation.
    Li J; Zhu J; Zou Y; Zhang G; Zhu P; Wang N; Xie P
    Eur J Radiol; 2024 Feb; 171():111301. PubMed ID: 38237522
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.
    Chen X; Luo Z; Hu Z; Sun D; He Y; Lu J; Chen L; Liu S
    Eur J Med Chem; 2024 Feb; 266():116082. PubMed ID: 38232462
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Minimally invasive liver resection for cholangiolocellular carcinoma: A single-institution experience.
    Kihara Y; Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
    Asian J Endosc Surg; 2024 Jan; 17(1):e13272. PubMed ID: 38212270
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
    Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
    Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.
    Zeng Y; Zhu C; Huang E; Xun Z; Zhang Y; Chen T; Lin C; Fu Y; Wu S; Yang B; Ou Q; Liu C
    Clin Chim Acta; 2024 Jan; 553():117739. PubMed ID: 38145642
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.
    Tai J; Hsu CW; Chen WT; Yang SS; Chiu CH; Chien RN; Chang ML
    Cancer Sci; 2024 Feb; 115(2):564-574. PubMed ID: 38083881
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Focal fatty sparing areas of the pediatric steatotic liver: pseudolesions on hepatobiliary phase magnetic resonance images.
    Özer G; Özcan HN; Oğuz B; Haliloğlu M
    Diagn Interv Radiol; 2024 Mar; 30(2):135-138. PubMed ID: 38032244
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Alcohol intake and cause-specific mortality: conventional and genetic evidence in a prospective cohort study of 512 000 adults in China.
    Millwood IY; Im PK; Bennett D; Hariri P; Yang L; Du H; Kartsonaki C; Lin K; Yu C; Chen Y; Sun D; Zhang N; Avery D; Schmidt D; Pei P; Chen J; Clarke R; Lv J; Peto R; Walters RG; Li L; Chen Z;
    Lancet Public Health; 2023 Dec; 8(12):e956-e967. PubMed ID: 38000378
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
    Zhang W; Chen Z; Sa B
    Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):129-134. PubMed ID: 37994618
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. aldh2 dysfunction and alcohol cooperate in cancer stem cell enrichment.
    Flashner S; Shimonosono M; Tomita Y; Matsuura N; Ohashi S; Muto M; Klein-Szanto AJ; Alan Diehl J; Chen CH; Mochly-Rosen D; Weinberg KI; Nakagawa H
    Carcinogenesis; 2024 Feb; 45(1-2):95-106. PubMed ID: 37978873
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study.
    Yao Y; Wang Y; Du Y; Jiang F; Liang H; Bi M; Xie H; Peng W; Pan Y
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111147. PubMed ID: 37956490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.